English
中文
CAS:179324-69-7
Storage:Powder:-20℃，2 years;Insolvent(Mother Liquid):-20℃，6 months;-80℃，1 year
Purity:HPLC≥98%
Appearance:White to off-white Solid
Manual Download
Examples of using this product（for reference only）
In Vitro:
Cell (Human PCa cell lines (PC3, LNCaP, C4-2, and Du145);3-1000ng/mL bortezomib):
To determine the IC50 concentration of bortezomib (Solarbio), 5×103 cells/well were seeded onto 96-well microtiter plates and were treated with different concentrations (3, 6, 12, 25, 50, 100, 200, 400, 800, and 1000ng/mL) of bortezomib and media supplemented with 5% fetal bovine serum. The CCK-8 assay was then performed to determine the 50% cell proliferation inhibition rate.
Reference：
Fu Z, Lu C, Zhang C, Qiao B. PSMA5 promotes the tumorigenic process of prostate cancer and is related to bortezomib resistance. Anticancer Drugs. 2019 Aug;30(7):e0773. doi: 10.1097/CAD.0000000000000773. PMID: 30807553.
